By binding to and activating the GLP-1 receptor, it mimics the natural incretin hormone GLP-1 to promote appetite suppression, delay gastric emptying, and increase insulin secretion while stabilizing glucose levels #Dapagliflozin (#Farxiga (US), #Forxiga (EU) by AstraZeneca) is an oral, once-daily SGLT2 inhibitor
The GLP-1RAs-associated weight loss is thought to be achieved through a variety of mechanisms, including the delayed gastric emptying, increased satiety, increased resting energy expenditure, as well as the direct influence of the appetite center of the brain (175)
doi: 10.1074/jbc.M110.191783 78 KlockgetherJ.TmmlerB
AMERICAS GLUTATHIONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION) TABLE 226
And, although the amount of weight lost was statistically significant, the average loss was 2.4 pounds (1.1 kg), not necessarily clinically significant